Spotti D, Slaviero G, Ferrari G, Carlucci M, Chiesa R, Melandri M, Quartagno R, Pozza G
Istituto Scientifico H San Raffaele, Università degli Studi di Milano.
Minerva Chir. 1991 Jun 30;46(12):685-8.
The aim of this study carried out on 33 uremic diabetic patients submitted to chronic hemodialytic treatment was to assess the kind of complications related to the vascular approach used as well as their short- and long-term incidences. Out of the 46 anastomoses prepared, 39 were arteriovenous fistulae according to Brescia-Cimino and 7 were PTFE grafts. The actuarial survival rate was 88%, 79%, and 63% after one, two and four years, respectively. The most frequent compliance was thrombosis. Our experience demonstrates that the distal arteriovenous fistula may be considered a valid vascular access for hemodialysis also in diabetic patients.
本研究针对33例接受慢性血液透析治疗的尿毒症糖尿病患者展开,旨在评估与所采用的血管通路相关的并发症类型及其短期和长期发生率。在所制备的46处吻合口中,39处为按照布雷西亚-西米诺法制作的动静脉内瘘,7处为聚四氟乙烯移植物。1年、2年和4年后的精算生存率分别为88%、79%和63%。最常见的并发症是血栓形成。我们的经验表明,远端动静脉内瘘也可被视为糖尿病患者进行血液透析的有效血管通路。